Nuveen’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Nuveen’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-21,592	Closed	-$271K	–	3373
2020 Q2	$271K	Buy	+21,592	New	+$302K	﹤0.01%	3049

Other funds holding BLPH

PCM

Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's BLPH Position: Q3 2020 in Review

Nuveen sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2020, closing a stake of 21,592 shares — an estimated $271K sold.

Nuveen first reported a position in BLPH in Q2 2020 and held it in 1 quarter. The position peaked at $271K in Q2 2020. 41 funds tracked by Wall St. Rank hold BLPH as of Q3 2020.

Nuveen reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Nuveen sold 21,592 Bellerophon Therapeutics, Inc. shares in Q3 2020, an estimated $271K.
Nuveen first reported a position in Bellerophon Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
Nuveen's Bellerophon Therapeutics, Inc. position peaked at $271K in Q2 2020.
41 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2020.

Based on Nuveen's 13F filing for Q3 2020, filed 16 Nov 2020.